98%
921
2 minutes
20
Elevated LDL-C/HDL-C ratio has been shown to be a marker of lipid metabolism as well as a good predictor of coronary artery disease (CAD). Thus, the aim of this study was to investigate whether the LDL-C/HDL-C ratio is useful for detecting cardiovascular disease (CVD) risk factors in general healthy Uygur adults in Xinjiang. A total of 4047 Uygur subjects aged ≥35 years were selected from the Cardiovascular Risk Survey (CRS) study which was carried out from October 2007 to March 2010. Anthropometric data, blood pressure, lipid profile and fasting glucose were measured in all participants. The prevalence, sensitivity, specificity and distance on the receiver operating characteristic (ROC) curve of each LDL-C/HDL-C ratio were calculated. The prevalence of high LDL-C and low HDL-C cholesterol was high and positively correlated with higher LDL-C/HDL-C ratio in the Uygur population. In both men and women, we detected a slight apparent trend of high prevalence of hypertension and hypercholesterolemia with higher LDL-C/HDL-C ratio. Our study also demonstrated that the discriminatory power of the LDL-C/HDL-C ratio for CVD risk factors was slightly stronger in men than in women. Analysis of the shortest distance in the ROC curves for hypertension, dyslipidemia, diabetes, or ≥two of these risk factors suggested a LDL-C/HDL-C ratio cutoff of 2.5 for both men and women. The results of this study showed that a LDL-C/HDL-C ratio cut-off of 2.5 might be used as the predictive marker to detect CVD risk factors among Uygur adults in Xinjiang.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772255 | PMC |
http://dx.doi.org/10.3390/ijerph13020235 | DOI Listing |
BMC Public Health
August 2025
Centre for Brain Research, Indian Institute of Science, Bangalore, 560012, India.
Background: Dyslipidemia is a major risk factor for cardiovascular diseases (CVD). The prevalence of dyslipidemia varies by geographic location, often higher in urban populations. Our study aimed to assess the prevalence of dyslipidemia in the aging Indian population and compare the rural-urban differences in lipid abnormalities.
View Article and Find Full Text PDFFront Oncol
August 2025
Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.
Background: Soft tissue sarcomas (STS) are rare malignancies with high relapse/metastasis risks and limited treatment efficacy. Current biomarkers like neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) lack comprehensive prognostic value due to their reliance on limited hematological parameters.
Methods: This retrospective study analyzed 206 STS patients (2016-2023) to develop a Composite Hematological Scoring System (CHSS) integrating 19 pretreatment markers.
Medicine (Baltimore)
August 2025
Department of Neurology, Affiliated Hospital of Jiangnan University, Wuxi City, Jiangsu Province, China.
This study investigates the association between non-motor symptoms (NMS) and serum lipid levels in patients with Parkinson disease (PD), and analyzes their potential clinical significance. A retrospective study was conducted, collecting data from 116 PD patients hospitalized at a certain hospital from February 2021 to January 2024. According to the total score of the NMS Scale, patients were divided into a mild NMS group (<41 points, n = 54) and a severe NMS group (≥41 points, n = 62).
View Article and Find Full Text PDFKardiol Pol
September 2025
Department of Cardiology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Background: The role of lipid markers in acute coronary syndrome remains incompletely understood, particularly for novel indices such as the Castelli risk indices (CRI-I, CRI-II) and cholesterol index (CHOINDEX).
Aims: This study aims to elucidate the relationship between novel lipid markers and plaque rupture.
Material And Methods: In this single-center retrospective study, 649 patients with acute coronary syndrome undergoing optical coherence tomography were stratified into plaque rupture (n = 130) and non-rupture (n = 519) groups.
Chin Med J (Engl)
September 2025
Department of Endocrinology and Metabolism, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.
Background: Studies on the impact of blood glucose indicators on metabolism remain relatively scarce. The aim of this study was to investigate the associations between blood glucose indicators and metabolic disorders in China.
Methods: Data were from the Thyroid disorders, Iodine status and Diabetes Epidemiological survey (TIDE survey), which randomly selected 31 cities from 31 provinces in the Chinese mainland.